Tamarack Advisers as of Dec. 31, 2015
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 30 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 16.1 | $122M | 600k | 203.87 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 12.5 | $95M | 788k | 120.58 | |
| Patterson Companies (PDCO) | 6.2 | $48M | 1.1M | 45.21 | |
| Quest Diagnostics Incorporated (DGX) | 6.1 | $46M | 650k | 71.14 | |
| Endologix | 5.8 | $44M | 4.5M | 9.90 | |
| NxStage Medical | 5.5 | $42M | 1.9M | 21.91 | |
| Medtronic (MDT) | 5.1 | $39M | 500k | 76.92 | |
| Greatbatch | 4.7 | $35M | 675k | 52.50 | |
| Allscripts Healthcare Solutions (MDRX) | 3.7 | $29M | 1.9M | 15.38 | |
| Becton, Dickinson and (BDX) | 3.5 | $27M | 175k | 154.10 | |
| Alkermes (ALKS) | 3.1 | $24M | 300k | 79.38 | |
| Spectranetics Corporation | 2.7 | $20M | 1.4M | 15.06 | |
| Luminex Corporation | 2.6 | $20M | 925k | 21.39 | |
| Imprivata | 2.6 | $20M | 1.7M | 11.30 | |
| Bio-Rad Laboratories (BIO) | 2.3 | $17M | 125k | 138.66 | |
| Perrigo Company (PRGO) | 2.2 | $17M | 118k | 144.70 | |
| AtriCure (ATRC) | 2.1 | $16M | 700k | 22.44 | |
| Steris | 2.1 | $16M | 209k | 75.34 | |
| AstraZeneca (AZN) | 1.8 | $14M | 400k | 33.95 | |
| Corium Intl | 1.5 | $11M | 1.4M | 8.12 | |
| Amarin Corporation (AMRN) | 1.4 | $10M | 5.5M | 1.89 | |
| Alere | 1.2 | $8.8M | 225k | 39.09 | |
| Express Scripts Holding | 1.1 | $8.7M | 100k | 87.41 | |
| Sagent Pharmaceuticals | 0.9 | $7.2M | 450k | 15.91 | |
| Teva Pharmaceutical Industries (TEVA) | 0.9 | $6.6M | 100k | 65.64 | |
| Intersect Ent | 0.7 | $5.6M | 249k | 22.50 | |
| RTI Biologics | 0.7 | $5.0M | 1.3M | 3.97 | |
| Varian Medical Systems | 0.4 | $2.8M | 35k | 80.80 | |
| Glaukos (GKOS) | 0.2 | $1.9M | 77k | 24.69 | |
| Streamline Health Solutions (STRM) | 0.2 | $1.6M | 1.1M | 1.41 |
